+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Live Cell Imaging Market - Growth, Trends, and Forecast (2019 - 2024)

  • ID: 4622559
  • Report
  • 120 pages
  • Mordor Intelligence
1 of 4


  • Carl Zeiss AG
  • GE Healthcare
  • Leica Microsystems
  • Molecular Devices, LCC
  • Nikon Corporation
  • Olympus Corporation
  • MORE
Market Overview

The growth of the live cell imaging market is attributed to the adoption of high-content screening techniques in drug discovery, the rising prevalence of chronic disease demanding higher and quicker diagnostic facilities, and government funding for cell-based research.

According to the World Health Organization (WHO), chronic disease is expected to increase by 57% by 2020. Increased demand for healthcare systems, due to the prevalence of chronic diseases, has become a major concern. Also, increasing age and lifestyle-related chronic diseases are increasing the healthcare demand and spending. In developing markets, cancer and heart diseases are becoming the main causes of death, owing to urbanization, sedentary lifestyles, changing diets, rising obesity levels, and widespread availability of tobacco products. As per WHO, China and India currently have the world’s highest number of diabetes sufferers; more than 98 million and 65 million individuals, respectively. Thus, due to the increasing prevalence of chronic diseases, there is a high demand for medical devices that enable early detection and quick diagnosis, which could prove to be particularly impactful.

Furthermore, government initiatives are also supporting cell-based research. For instance, the National Center for Advancing Translational Sciences (NCATS) Small Business Innovation Research (SBIR) is offering a new funding opportunity to small businesses that are focused on assays and high-throughput screening. Thus, all these efforts are expected to augment the growth of the market over the forecast period.

Scope of the Report

As per the scope of this report, live cell imaging techniques allow the real-time examination of every aspect of cellular function under normal and experimental examinations.

Key Market Trends

Equipment Segment Under Product is Expected to Grow Fastest During the Forecast Period

The equipment segment held the maximum share in 2018. They include microscopes, cell analyzers, image capturing systems, and standalone systems. Recent technological advancements in microscopes have augmented the growth of the market. For instance, inverted research grade microscope has supported imaging of adherent cells and organelles and yield results for tissue sections of less than 5 um thickness. The overall industry trend is shifting toward automation, integration of systems, and maximizing data generation from microscopes. The increasing use of live cell imaging among cell biologists to understand the fundamental nature of the cell function and structure has resulted in the aforementioned shift.

North America Region Holds the Largest Market Share of Live Cell Imaging Market Market Currently and is Believed to Follow the Same Trend over the Forecast Period

North America dominated the market share in 2018. The generous investment and funding available for research in live cell imaging is the key driver in this region. Also, in 2016, the Government of Canada announced the funding to support the Canada Research Chairs Program. This fund was a part of total funding of worth more than USD 164 million that was allocated for infrastructure. Projects on cell imaging in plant development, which are untaken by the McGill University, are also included in this program.

Competitive Landscape

The live cell imaging market consists of several major players, including Becton, Dickinson and Company, Carl Zeiss, and Leica Microsystems, among many others. The companies are implementing certain strategic initiatives, such as mergers, new product launches, acquisitions, and partnerships that help them in strengthening their market position. For instance, in March 2018, Nikon Corporation released a new product new N-SIM S Super-Resolution Microscope, which enables super-solution imaging of live cells at 10 times greater than the speed of conventional structured illumination microscopy (SIM).
Note: Product cover images may vary from those shown
2 of 4


  • Carl Zeiss AG
  • GE Healthcare
  • Leica Microsystems
  • Molecular Devices, LCC
  • Nikon Corporation
  • Olympus Corporation
  • MORE
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study



4.1 Market Overview
4.2 Market Drivers
4.2.1 Adoption of High-Content Screening Techniques in Drug Discovery
4.2.2 Rising Prevalence of Chronic Disease Demanding Higher & Quicker Diagnostic Facilities
4.2.3 Government Funding for Cell-Based Research
4.3 Market Restraints
4.3.1 High Cost of High-Content Screening Systems
4.3.2 Shortage of Skilled Professionals
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5.1 By Product
5.1.1 Equipment Standalone Systems Microscopes Cell Analyzers Image Capturing Devices
5.1.2 Consumables Assay Kits Reagents Media Other Consumables
5.2 By Technology
5.2.1 Fluorescence Resonance Energy Transfer (FRET)
5.2.2 Fluorescence in Situ Hybridization (FISH)
5.2.3 High-Content Screening (HCS)
5.2.4 Fluorescence Recovery After Photobleaching (FRAP)
5.2.5 Ratiometric Imaging
5.2.6 Total Internal Reflection Fluorescence Microscopy (TRIF)
5.2.7 Multiphoton Excitation Microscopy (MPE)
5.2.8 Others
5.3 By Application
5.3.1 Cell Biology
5.3.2 Developmental Biology
5.3.3 Stem Cell Biology
5.3.4 Drug Discovery
5.4 Geography
5.4.1 North America US Canada Mexico
5.4.2 Europe Germany UK France Italy Spain Rest of Europe
5.4.3 Asia Pacific China Japan India Australia South Korea Rest of Asia-Pacific
5.4.4 Middle East and Africa GCC South Africa Rest of Middle East and Africa
5.4.5 South America Brazil Argentina Rest of South America

6.1 Company Profiles
6.1.1 Becton, Dickinson and Company
6.1.2 Carl Zeiss AG
6.1.3 GE Healthcare
6.1.4 Leica Microsystems
6.1.5 Olympus Corporation
6.1.6 Molecular Devices, LCC
6.1.7 Nikon Corporation
6.1.8 PerkinElmer, Inc.
6.1.9 Sigma-Aldrich Corporation
6.1.10 Thermo Fisher Scientific, Inc.

Note: Product cover images may vary from those shown
3 of 4


4 of 4
  • Becton, Dickinson and Company
  • Carl Zeiss AG
  • GE Healthcare
  • Leica Microsystems
  • Olympus Corporation
  • Molecular Devices, LCC
  • Nikon Corporation
  • PerkinElmer, Inc.
  • Sigma-Aldrich Corporation
  • Thermo Fisher Scientific, Inc.
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4622559